Invention Grant
- Patent Title: Crystalline forms of a neuroactive steroid
-
Application No.: US18363942Application Date: 2023-08-02
-
Publication No.: US11952397B2Publication Date: 2024-04-09
- Inventor: Shanming Kuang , Tianrui Li
- Applicant: Sage Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Sage Therapeutics, Inc.
- Current Assignee: Sage Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Honigman LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- Main IPC: C07J43/00
- IPC: C07J43/00
Abstract:
This invention relates to crystalline forms of anhydrous Compound (1) and pharmaceutical compositions thereof. Also disclosed herein are methods of making crystalline solid forms of Compound (1), and methods of using the crystalline forms of Compound (1) and pharmaceutical compositions thereof for modulating GABA activity (e.g., positive allosteric modulation of GABA activity) and treating CNS-related disorders.
Public/Granted literature
- US20230374061A1 CRYSTALLINE FORMS OF A NEUROACTIVE STEROID Public/Granted day:2023-11-23
Information query
